Skip to main content

3 Result(s)

within Article Remove this filter **u-li Gong Remove this filter Cancer Research Remove this filter Oncology Remove this filter

and
Your search also matched 4 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

Include preview-only content

  1. Article

    Open Access

    ACE2-independent infection of T lymphocytes by SARS-CoV-2

    SARS-CoV-2 induced marked lymphopenia in severe patients with COVID-19. However, whether lymphocytes are targets of viral infection is yet to be determined, although SARS-CoV-2 RNA or antigen has been identifi...

    Xu-Rui Shen, Rong Geng, Qian Li, Ying Chen… in Signal Transduction and Targeted Therapy (2022)

    Download PDF (4015 KB) View Article

  2. Article

    Open Access

    Targeting HNRNPU to overcome cisplatin resistance in bladder cancer

    The overall response of cisplatin-based chemotherapy in bladder urothelial carcinoma (BUC) remains unsatisfactory due to the complex pathological subtypes, genomic difference, and drug resistance. The genes th...

    Zhen-duo Shi, Lin Hao, **ao-xiao Han, Zhuo-Xun Wu, Kun Pang, Yang Dong… in Molecular Cancer (2022)

    Download PDF (7091 KB) View Article

  3. Article

    Open Access

    Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002–2011)

    Esophageal cancer is associated with substantial disease burden in China, and data on the economic burden are fundamental for setting priorities in cancer interventions. The medical expenditure for the diagnos...

    Lan-Wei Guo, Hui-Yao Huang, Ju-Fang Shi, Li-Hong Lv, Ya-Na Bai… in Chinese Journal of Cancer (2017)

    Download PDF (2751 KB) View Article